Trial intelligence / Profile preview

BATTLE-AMI: Statins and P2Y12 Inhibitors in STEMI

NCT02428374Phase 4Unknown

Sponsor
Federal University of São Paulo
Start
May 2015
Primary completion
Apr 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin, ticagrelor in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Federal University of São Paulo. Status: unknown.

02

Drugs

rosuvastatinticagrelor
03

Conditions

acute ST-segment elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02428374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02428374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call